Gadobutrol
C18H31GdN4O9·H2O
622.73
C18H31GdN4O9 604.72
Gadolinium, [10-[2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1, κN4, κN7, κN10, κO1, κO4, κO7]-, monohydrate, [SA-8-1425362′5′-(R*,S*)]-;
Gadolinium(III) [10-[(2RS,3SR)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetate] monohydrate
[198637-52-4] Anhydrous [770691-21-9]
C18H31GdN4O9 604.72
Gadolinium, [10-[2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1, κN4, κN7, κN10, κO1, κO4, κO7]-, monohydrate, [SA-8-1425362′5′-(R*,S*)]-;
Gadolinium(III) [10-[(2RS,3SR)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetate] monohydrate
[198637-52-4] Anhydrous [770691-21-9]
DEFINITION
Gadobutrol contains NLT 98.0% and NMT 102.0% of gadobutrol (C18H31GdN4O9) on the anhydrous basis.